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Objectives: Biventricular pacing acutely improves left ventricular function in patients with heart failure and
left ventricular dyssynchrony. Pressure-volume loop analysis has shown acute perioperative hemodynamic
benefits of biventricular pacing immediately after weaning from cardiopulmonary bypass in patients under-
going coronary artery bypass grafting, but whether these effects can be maintained for the early postoperative
period is unclear. We hypothesized that biventricular pacing is superior to atrioventricular universal pacing
at right ventricular outflowtract and atrial inhibited pacing in patients undergoing coronary artery bypass
grafting.
Methods: Ninety-four patients (mean age, 67  9 years; mean ejection fraction, 35%  4%) were prospec-
tively randomized to undergo biventricular, atrioventricular universal, or atrial inhibited pacing at 90 beats/
min for 96 postoperative hours. Clinical end points and postoperative hemodynamics, aminoterminal pro–
brain natriuretic peptide, inotropic support, atrial fibrillation, ventricular arrhythmias, and renal function
were evaluated.
Results: Diastolic pulmonary arterial pressure, mean arterial pressure, mixed venous saturation, cardiac index,
and cardiac power index did not differ significantly among groups for all time points. Neither raw aminoterminal
pro–brain natriuretic peptide nor differential from preoperative values differed significantly among groups at any
time point. Median intensive care unit stay (19.5 hours) did not differ significantly by pacing mode. Incidences of
postoperative atrial fibrillation were 40% for atrial inhibited, 29% for atrioventricular universal, and 37% for
biventricular (differences not significant). Renal function was unaffected by pacing mode.
Conclusion: Despite short-term hemodynamic benefits for patients with reduced left ventricular function, biven-
tricular pacing did not lead to improved postoperative hemodynamics or clinical outcome.Earn CME credits at
http://cme.ctsnetjournals.org
Atrioventricular synchronous biventricular pacing (DDD-
BIV) represents an effective therapeutic modality that
acutely improves systolic function in the patient with heart
failure, left ventricular (LV) ejection fraction (EF) less than
35%, and QRS width greater than 120 ms.1,2 The concept
of transferring these acute hemodynamic benefits to the car-
diac surgical patient with ischemic heart disease and reduced
LV function is attractive. Recently, acute improvements in
the range of 10% to 15% in cardiac output, stroke work,
and the first derivative of LV pressure rise have been shown
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nous pacing at the right ventricular (RV) outflow tract
(DDD-RVOT) in a study of intraoperative pressure-volume
loop analysis in patients with ischemic cardiomyopathy after
weaning from cardiopulmonary bypass (CPB).3
In accordance with these promising intraoperative results,
prolonged DDD-BIV might be an additional option after cor-
onary artery bypass grafting (CABG) during the early postop-
erative period to improve postoperative hemodynamics,
reduce postoperative inotrope and vasopressor needs, and im-
prove clinical outcome in patients with reduced LV function.
Although the postoperative stability of the additional LV epi-
cardial pacing wire and the general feasibility of DDD-BIV
pacing with standard external pacemaker devices have been
documented, the overall effect of DDD-BIV relative to stan-
dard pacing modes in the early postoperative period is un-
known.4,5 A prospective, randomized, single-center study
was therefore designed to evaluate the effect of biventricular
pacing after CABG (http://clinicaltrials.gov/NCT00417092)
relative to DDD-RVOT and atrial inhibited pacing (AAI) on
early postoperative hemodynamics, arrhythmias, renal func-
tion, and clinical outcomeparameters inpatientswith ischemic
heart disease and severely reduced LV function (EF<40%)
undergoing CABG in a prospective, randomized setting.rdiovascular Surgery c Volume 137, Number 6 1461
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AAI ¼ atrial inhibited pacing
CABG ¼ coronary artery bypass grafting
CPB ¼ cardiopulmonary bypass
DDD-BIV ¼ atrioventricular synchronous
biventricular pacing
DDD-RVOT ¼ atrioventricular synchronous pacing
at right ventricular outflow tract
EF ¼ ejection fraction
GFR ¼ glomerular filtration rate
LV ¼ left ventricular
NT-pro-BNP ¼ aminoterminal pro-brain natriuretic
peptide
RIFLE ¼ risk of renal failure, injury to
kidney, failure of kidney function,
loss of kidney function and
end-stage renal failure
RV ¼ right ventricular
VVI ¼ ventricular-only demand pacing
MATERIALS AND METHODS
Patients
One hundred patients undergoing elective or urgent CABG with LV EF
less than 40% between December 2005 and June 2007 were included in the
study. The study protocol was approved by the institutional review board,
and all patients gave written, informed consent.
Protocol
All patients undergoing CABG, either on a scheduled basis or on an ur-
gent emergency setup, at the University of Lu¨beck were screened for the
study. If EF was less than 40% at ventriculography, patients were asked
to provide written, informed consent to be included in the study. Exclusion
criteria were concomitant valve or aortic surgery, presence of a permanent
pacemaker or implantable cardioverter defibrillator system, terminal renal
failure, and inability to provide written, informed consent. Patients were
stratified according to the presence of preoperative paroxysmal or perma-
nent atrial fibrillation (AF) and the presence of preoperative bundle branch
block, defined as a QRS width greater than 120 ms. Subsequently, patients
received a sealed envelope that contained the random assignment to one of
three postoperative pacing modes (DDD-BIV, DDD-RVOT, or AAI). All
patients were equipped with a central venous line, an arterial line, and a pul-
monary artery thermodilution catheter (Edwards Lifesciences LLC, Irvine,
Calif). Fluid management was adjusted to maintain a central venous pres-
sure of 8 to 12 mm Hg and a pulmonary arterial diastolic pressure of 15
to 18 mm Hg. Routine CABG was performed in moderate hypothermia
(32C nasopharyngeal temperature) with antegrade blood cardioplegia. Be-
fore weaning from CPB, unipolar pacing wires (Streamline 6500; Med-
tronic, Inc, Minneapolis, Minn) were sutured onto the roof of the right
atrium, onto the RV outflow tract in a high paraseptal position, and onto
the lateral free wall of the LV and connected to a dual-chamber external
pacemaker (Pace 203H; Osypka, Rheinfelden-Herten, Germany). Weaning
from CPB was accomplished in standard fashion.
After weaning from CPB, the randomization envelope was opened, and
pacing was conducted as either DDD-BIV, DDD-RVOT, or AAI. Stimula-
tion rate was kept at 90 beats/min for 96 postoperative hours, analogous to
the studies on preventing postoperative AF.6 Patients with sustained AF af-
ter weaning from CPB were excluded from further analysis. If AF occurred1462 The Journal of Thoracic and Cardiovascular Sduring the further postoperative period, the external pacemaker was pro-
grammed to ventricular-only demand pacing (VVI) for the duration of AF
and switched back to the randomized pacing mode after termination of
the AF episode. VVI pacing during AF was instituted along the same prin-
ciples as the randomized pacing modes as minimal ventricular pacing (AAI
90 beats/min changed to VVI at 50 beats/min), RV outflow tract pacing
(DDD-RVOT at 90 beats/min changed to RV outflow tract VVI at 90
beats/min), or biventricular pacing (DDD-BIV at 90 beats/min changed to
biventricular VVI at 90 beats/min). Termination of AF was attempted either
by intravenous infusion of amiodarone (450mg) during 2 hours followed by
constant amiodarone infusion (900 mg/d) or by immediate electrical cardi-
oversion in a standard fashion in case of hemodynamic instability. Postop-
erative b-blocker therapy was instituted if hemodynamically tolerable. The
atrioventricular delay was programmed at 150 ms during DDD-RVOT and
120 ms during DDD-BIV to ensure true biventricular capture. Atrial sensi-
tivity was programmed at a default value of 0.5 mV and could be lowered to
0.2 mV to obtain at least a 3-fold safety margin. Ventricular sensitivity was
programmed to a minimum programmable value of 1.0 mV. Pacing output
was programmed to a 3-fold safety margin. Lower safety margins were al-
lowed in case of chest wall stimulation. Pacing and sensing thresholds were
measured every 8 hours to ensure proper pacemaker function. After surgery,
the patient was transferred to the intensive care unit. In accordance with the
institutional standard, patients were transferred to an intermediate care unit
within 24 hours if in clinically stable condition without the need for cate-
cholamines or inotropes.
Hemodynamic Parameters and Inotropes
If the heart was clinically hypocontractile or the stroke volume index was
below 35 mL/m2 despite raised filling pressures (central venous pressure
>15 mm Hg, pulmonary arterial diastolic pressure>18 mm Hg), inotropic
support with enoximone (INN) and dobutamine was started.7 Norepineph-
rine was added to maintain mean arterial pressure above 65 mm Hg. Cumu-
lative and maximum doses of enoximone, dobutamine, and norepinephrine
were recorded for each patient.
Central venous pressure, mean and diastolic pulmonary arterial pres-
sures, mean arterial pressure, and mixed venous saturation were measured
hourly until removal of the thermodilution catheter. Thermodilution cardiac
output, cardiac index, was determined hourly as the average of three mea-
surements. Cardiac power index was calculated to correct cardiac index
for ventricular afterload as follows8: cardiac power index ¼ cardiac
index/mean arterial pressure 3 0.00222 W/s.
Arrhythmias
Patients were continuously monitored (Infinity Kappa; Dra¨ger, Lu¨beck,
Germany). The numbers of AF episodes, ventricular tachycardia episodes,
and defibrillations were noted, as was the cumulative amiodarone dose.
Serum Parameters
Creatine kinase MB fraction and troponin T were measured preopera-
tively, immediately postoperatively on arrival at the intensive care unit,
and at 24 and 96 postoperative hours. For the determination of the amino-
terminal pro–brain natriuretic peptide (NT-pro-BNP), ethylenediaminete-
traacetic acid–treated blood samples were also collected at these time
points, immediately centrifuged at 3500g for 10 minutes, and stored at
70C. NT-pro-BNP was measured with commercially available assays
(ECLIA Elecsys 2010 analyzer; F. Hoffmann-La Roche AG, Basel,
Switzerland) in plasma samples never previously thawed.
Renal Function
Urinary output was measured hourly. Creatinine concentrations were
measured every 8 hours during the first 24 hours and every 24 hours there-
after. Glomerular filtration rate (GFR) was determined by the Modification
of Diet in Renal Disease formula. GFR and urinary output were combined tourgery c June 2009
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All (n ¼ 94) AAI (n ¼ 30) DDD-RVOT (n ¼ 31) DDD-BIV (n ¼ 33)
Age (y, mean  SD) 67  9 66  10 67  9 67  7
Sex (% male) 77% 84% 70% 75%
Euroscore (mean  SD) 9.2  2.7 8.9  2.7 9.3  2.8 8.0  2.6
New York Heart Association functional class (mean  SD) 2.1  1.2 2.1  1.1 1.9  1.3 2.2  1.2
Canadian Cardiovascular Society class (mean  SD) 2.0  1.5 2.0  1.6 1.7  1.3 2.2  1.7
Mitral regurgitation (mean  SD) 1.0  0.8 1.1  0.9 0.8  0.8 1.1  0.8
Previous coronary artery bypass grafting (%) 3% 7% 6% 0%
Previous myocardial infarction (%) 60% 73% 53% 58%
Acute myocardial infarction (%) 20% 13% 29% 16%
Ejection fraction (%, mean  SD) 35%  4% 35%  3% 34%  5% 34%  5%
Bundle-branch block (%) 6% 7% 0% 10%
QRS width (ms, mean  SD) 100  16 98  16 102  12 99  20
PQ time (ms, mean  SD) 165  29 163  32 163  25 168  32
Preoperative sinus rhythm (%) 88% 93% 88% 84%
Troponin T positivity (%) 29% 40% 24% 26%
Preoperative medication (%)
Aspirin 70% 80% 76% 56%
Clopidogrel 16% 20% 18% 11%
b-Blocker 88% 73% 94% 94%
Calcium-channel antagonist 26% 40% 24 17
Angiotensin-converting enzyme inhibitor 68% 73% 71 61
Angiotensin II type 1 antagonist 18% 20% 6% 22%
Aldosterone antagonist 15% 17% 10% 18%
Loop diuretic 46% 40% 41% 56%
Thiazide 23% 20% 23% 27%
Statin 82% 79% 89% 76%
There were no significant differences among the groups. AAI,Atrial inhibited pacing;DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract;DDD-BIV,
atrioventricular synchronous biventricular pacing.obtain the postoperative RIFLE (risk of renal failure, injury to kidney, fail-
ure of kidney function, loss of kidney function, and end-stage renal failure)
score.9 Briefly, a RIFLE score of 1 (risk) is defined as a decrease in GRF
greater than 25% or a urinary output less than 0.5 mL/(kg $ h) for 6 hours,
a RIFLE score of 2 (injury) is defined as a decrease in GFR greater than 50%
or a urinary output less than 0.5 mL/(kg $ h) for 12 hours, and a RIFLE score
of 3 (failure) is defined as a decrease in GFR greater than 75% or a urinary
output less than 0.3 mL/(kg $ h) for 24 hours or anuria. Cumulative RIFLE
scores for the entire postoperative period were obtained for each patient.
Moreover, the use of continuous venovenous hemofiltration was noted.
Clinical Outcome Parameters
The 28-day survival status, the intensive care unit stay, and the hospital
stay were recorded for each patient. Duration of intensive care unit stay was
left to the clinical discretion of the intensive care unit physician in charge.
Further clinical outcome parameters were postoperative myocardial infarc-
tion, need for postoperative revascularization, use of an intra-aortic balloon
pump, rethoracotomy, and stroke.Statistical Analysis
Statistical analyses were performed with SPSS for Windows version
10.0.1 (SPSS Inc, Chicago, Ill). Data are expressed as mean  SD. Results
per treatment group were analyzed on an intent-to-treat basis.
Continuous variables were analyzed for differences between pacing
groups by 1-way analysis of variance with post hoc Bonferroni correction
with a 95% confidence interval. Categoric variables were compared with
the c2 test. On the basis of hemodynamic data obtained by pressure–volume
loop analysis,3 the trial was designed to detect a 15% difference in cardiac
power index assuming an average a priori value of 0.6  0.10 W/m2 at an
a value of .05 and a statistical power of .80. Under the design assumptions,
a target size of 33 patients per group was calculated.
RESULTS
Preoperative and Intraoperative Data
Follow-up was 100% complete. Six patients were ex-
cluded from the analysis because of incomplete study dataTABLE 2. Intraoperative data
All (n ¼ 94) AAI (n ¼ 30) DDD-RVOT (n ¼ 31) DDD-BIV (n ¼ 33)
Aortic crossclamp time (min, mean  SD) 86  37 81  32 88  43 87  34
Cardiopulmonary bypass time (min, mean  SD) 105  39 106  36 100  28 115  42
Veins (No., mean  SD) 2.0  1.1 1.9  1.1 2.2  1.0 1.8  1.2
Left internal thoracic artery graft (%) 93% 90% 94% 94%
Second arterial bypass (%) 19% 23% 6% 27%
Intra-aortic balloon pump (%) 4.3% 0% 1.1% 3.2%
There were no significant differences among the groups. AAI,Atrial inhibited pacing;DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract;DDD-BIV,
atrioventricular synchronous biventricular pacing.
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ative patient characteristics and preoperative medication
were consistent with a patient population with ischemic car-
diomyopathy at an increased perioperative risk with a mean
TABLE 3. Clinical end points in relation to pacing mode
All
(n ¼ 94)
AAI
(n ¼ 30)
DDD-RVOT
(n ¼ 31)
DDD-BIV
(n ¼ 33)
Mortality (No.) 3 1 1 1
Cerebrovascular
accident (No.)
1 0 1 0
Postoperative
myocardial infarction
(No.)
1 0 0 0
Postoperative
revascularization (No.)
1 0 0 1
Intra-aortic balloon
pump (No.)
4 0 1 3
Continuous venovenous
hemofiltration (No.)
3 0 1 2
Rethoracotomy (No.) 4 1 0 3
Intensive care
unit stay (h)
Mean  SD 52  93 44  93 37  51 74  122
Median 20 21 19 20
Combined end point
without
rethoracotomy (No.)
10 1 3 6
There were no significant differences among the groups. AAI, Atrial inhibited pacing;
DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract;
DDD-BIV, atrioventricular synchronous biventricular pacing.EuroSCORE of 9.2 (Table 1). Intraoperative patient charac-
teristics revealed no significant differences among pacing
groups (Table 2).
Outcome Data
Clinical outcome parameters are presented in Table 3. No
deaths were recorded during the stimulation period of 96
hours. Further early (30-day) mortality was 3.1% (n ¼ 3).
Causes of death were cardiac in 1 case (cardiogenic shock)
and noncardiac in 2 (septic shock). The overall incidences
of relevant clinical end points were comparatively low (Ta-
ble 3). The randomly assigned pacing mode could be main-
tained for 96 hours in 96% of the AAI group, 94% of the
DDD-RVOT group, and 92% of the DDD-BIV group. Rea-
son for pacing discontinuation was lead failure with loss of
stimulation or sensing that could not be rectified by adjust-
ment of the temporary pacemaker device. Pacing had to be
discontinued in 1 patient in the DDD-BIV group because
of diaphragmatic stimulation. With the exception of central
venous pressure, no significant differences could be detected
among groups for any hemodynamic parameter (Figure 1).
Mean cardiac index at 12 postoperative hours was 3.23 
0.74 L/(min $ m2); mean cardiac power index was 0.54 
0.14 W/m2. The median preoperative NT-pro-BNP level
was 1669 pg/mL (Figure 2). NT-pro-BNP, troponin T, and
creatine kinase levels were in the same range at various pre-
operative and postoperative time points, with no significant
differences among pacing groups. Differential values be-
tween preoperative and postoperative measurements didFIGURE 1. Postoperative hemodynamics in relation to postoperative pacing mode. Significant differences between atrial inhibited pacing and atrioventric-
ular synchronous biventricular pacing (P< .05) are marked with asterisks. CVP, Central venous pressure; PAP, pulmonary arterial pressure; MAP, mean
arterial pressure; AAI, atrial inhibited pacing; DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract; DDD-BIV, atrioventricular
synchronous biventricular pacing.
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Eberhardt et al Acquired Cardiovascular DiseaseFIGURE 2. Time courses of aminoterminal pro–brain natriuretic peptide (NT-pro-BNP, left panel), troponin T (middle panel), and creatine kinase isoenzyme
MB (CK-MB, right panel) in relation to pacing mode. There were no significant differences among pacing groups. AAI,Atrial inhibited pacing;DDD-RVOT,
atrioventricular synchronous pacing at right ventricular outflow tract; DDD-BIV, atrioventricular synchronous biventricular pacing; pre-OP, preoperative;
post-OP, postoperative.A
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tive application of inotropes and vasopressors did not differ
among pacing groups (Figure 3). The incidences of AF and
ventricular arrhythmias and the use of amiodarone are dis-
played in Figure 4. Although the incidence of AF was sim-
ilar among groups, patients in the DDD-BIV group did show
a tendency toward higher amiodarone doses than patients in
the AAI group to maintain sinus rhythm (P ¼.05). Preoper-
ative creatinine clearance was normal and did not change
significantly in the postoperative time course (Figure 5). RI-
FLE score was significantly lower only at 24 postoperative
hours in the DDD-RVOT group relative to the DDD-BIV
group. The number of patients with a cumulative RIFLE
score greater than 1 was not statistically different among
groups for the entire observational period (AAI 17%,
DDD-RVOT 16%, DDD-BIV 26%).
DISCUSSION
To our knowledge, this is the first prospective, random-
ized study to compare in a 96-hour period temporary postop-
erative DDD-BIV with standard pacing modes in a
homogeneous population of patients with depressed LV
function undergoing pure coronary artery revascularization.
No significant differences were seen among DDD-BIV,
DDD-RVOT, and AAI groups for a variety of clinical and
hemodynamic parameters.DDD-BIVAfter CABG
DDD-BIV improves symptoms, quality of life, exercise
tolerance, and mortality for patients with acute and chronic
heart failure who have an EF less than 35% and a widened
QRS complex.10,11 An acute response to DDD-BIV among
these patients is documented during pressure–volume loop
analysis, and these effects are maintained for at least 6
months.1,2,12 DDD-BIV to improve LV function after gen-
eral cardiac surgery has been investigated in a few studies,
with diverse results.5,13-16 Several methodologic drawbacks
apply to these studies. Some studies included patients with
additional valve surgery5,15 or patients with maintained
LV function.13 Other studies used paraseptal pacing sites
for both RV and LV leads, although the free lateral wall
has proved to be the most effective LV pacing wire
position.17 All studies have in common that only a single,
sometimes variable point in time was used for hemodynamic
measurements after cardiac surgery. A pressure–volume
loop analysis immediately after weaning from CPB in
patients with normal QRS complex and severely reduced
LV function (EF<35%) showed improvement in systolic
function parameters in the range of 10% to 15% for
DDD-BIV and AAI relative to DDD-RVOT pacing, with
diastolic parameters remaining largely unaffected.3 These
acute hemodynamic effects, however, only apply to the
immediate perioperative period after weaning from CPB inFIGURE 3. Cumulative doses during first 24 postoperative hours for norepinephrine (noradrenaline, left panel), dobutamine (middle panel), and milrinone
(right panel) in relation to pacing mode. There were no significant differences among pacing groups. AAI, Atrial inhibited pacing; DDD-RVOT, atrioventric-
ular synchronous pacing at right ventricular outflow tract; DDD-BIV, atrioventricular synchronous biventricular pacing.
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middle panel) and amiodarone dose (right panel) during 96-hour stimulation period in relation to pacing mode. There were no significant differences among
pacing groups. AAI, Atrial inhibited pacing; DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract; DDD-BIV, atrioventricular
synchronous biventricular pacing.an open-chest situation with rapid volume changes and high
levels of inotropes or vasopressors.
This study was designed to determine from longitudinal
measurements whether these beneficial hemodynamic ef-
fects of DDD-BVI and AAI relative to DDD-RVOT could
be maintained for the early 96-hour postoperative period.
Additional positive hemodynamic or clinical effects of
DDD-BIV relative to DDD-RVOT and AAI were not detect-
able during the study period. Cardiac power index, which
proved to be the strongest hemodynamic correlate of mortal-
ity during cardiogenic shock in the SHOCK trial,8 did not
differ among stimulation groups. Mixed venous saturation,
which has been proved to be a valid prognostic factor in
the postoperative care of cardiac surgical patients,18 was
also similar among pacing groups. Levels of enzymes rele-
vant to cardiac surgery (eg, NT-pro-BNP, creatine kinase,
MB fraction of creatine kinase) were in the typical range
for a patient population with severely reduced LV function
preoperatively and did not differ among groups postopera-
tively.19-21 The hemodynamic results are supported by the
inotrope and vasopressor needs, which were not signifi-
cantly different among groups. Additionally, the overall
incidence of renal dysfunction was low in our patient popu-
lation, with no overall differences among groups at 96 post-operative hours. The average incidence of postoperative AF
was in the same range as reported previously for patients
with reduced LV function undergoing CABG6 and was
not influenced by the choice of pacing mode.
Essentially, DDD-BIV in our study was not superior to
DDD-RVOT and AAI with regard to a wide variety of pa-
rameters in the observed patient group and even showed
a tendency toward a negative outcome for some parameters.
Although the distributions of preoperative and intraopera-
tive characteristics were similar among stimulation groups,
3 patients in the DDD-BIV group had prolonged intensive
care unit stays, with concurrent adverse hemodynamics
and vasopressor and inotrope needs because of respirator-as-
sociated pneumonia and postoperative sepsis. This may have
tilted the results in an unfavorable direction for DDD-BIV.
Another factor that might explain the lack of superiority of
DDD-BIV is that the observed patient population was not
preoperatively screened for mechanical dyssynchrony. Me-
chanical dyssynchrony can be determined by QRS width
or echocardiographic parameters; however, the relationship
between QRS duration and LV intraventricular dyssyn-
chrony is not very strong, and a high degree of dyssynchrony
may be present in patients with normal QRS complexes.22
Moreover, the relationship between preoperative andFIGURE 5. Creatinine clearance (by Modification of Diet in Renal Disease method, left panel) and RIFLE score (left panel) in relation to pacing mode.
Significant difference (P<.05) between atrioventricular synchronous pacing at right ventricular outflow tract and atrioventricular synchronous biventricular
pacing is marked with asterisk. AAI, Atrial inhibited pacing; DDD-RVOT, atrioventricular synchronous pacing at right ventricular outflow tract; DDD-BIV,
atrioventricular synchronous biventricular pacing; pre-OP, preoperative; post-OP, postoperative.
1466 The Journal of Thoracic and Cardiovascular Surgery c June 2009
Eberhardt et al Acquired Cardiovascular Disease
A
C
Dpostoperative dyssynchrony after CPB is unclear. Mechani-
cal dyssynchrony occurs after weaning from CPB as a result
of regional myocardial edema despite normal preoperative
QRS complexes.23 In this situation, both DDD-BIV and
AAI have been reported to be hemodynamically superior
to DDD-RVOT in a similar patient population immediately
after weaning from CPB.3 With restoration of myocardial
function after cardiac surgery with the use of extracorporeal
circulation, the positive effect of DDD-BIV obviously disap-
pears. On the basis of the observed data, DDD-BIV thus
lacks clinical and hemodynamic superiority in the early post-
operative period for patients with severely reduced LV func-
tion and normal QRS complex. Even if the potentially
deleterious effects of RV pacing are to be avoided in those
patients who require mandatory pacing for perioperative
bradyarrythmia, DDD-BIV is not superior to DDD-
RVOT.24,25 This finding may also be explained by the fact
that epicardial high paraseptal DDD-RVOT results in less
LV dyssynchrony than does endocardial apical RV pacing.24
Although it remains a matter of speculation, postoperative
DDD-BIV pacing might be of benefit for a carefully selected
cardiac surgical subgroup of patients with severely reduced
LV function (EF 25%), a wide QRS complex, or docu-
mented interventricular dyssynchrony.
LIMITATIONS
Variations of all three pacing wire positions are possible.
Although left atrial or biatrial pacing has been suggested to
reduce the incidence of postoperative AF, conclusive evi-
dence of clinical superiority relative to right atrial pacing
is lacking.6 In general, the outcome after cardiac surgery
in a high-risk patient population is governed by many clini-
cal factors, some of which are difficult to control for in a pro-
spective, randomized study design.
CONCLUSIONS
Routine use of temporary DDD-BIV pacing in patients
undergoing CABG with severely reduced LV function and
normal QRS complex cannot be recommended on the basis
of the observed data. DDD-BIV pacing in this patient cohort
did not improve postoperative hemodynamics or clinical
outcome relative to DDD-RVOT or AAI.
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